PURPOSE: Global DNA hypomethylation plays an important role in genomic instability and carcinogenesis. The long interspersed nucleotide element-1 (LINE-1) methylation level is a good surrogate marker of the global DNA methylation level. Previously, we demonstrated a strong relationship between LINE-1 hypomethylation and poor prognosis in certain cancers. However, the relationship between the LINE-1 methylation level and the clinical outcome of pancreatic cancer (PC) remains unclear. METHODS: We used a pyrosequencing assay to measure LINE-1 methylation levels in 126 samples of resected PC and evaluated the prognostic value of the LINE-1 methylation level. RESULTS: LINE-1 methylation levels were significantly lower in PC tissues than in matched noncancerous pancreatic tissues (p = 0.039, n = 36). The tumoral LINE-1 methylation range was 41.3-92.8 (n = 126, mean 77.7, median 78.5, standard deviation 5.7). The LINE-1 methylation level was unrelated to clinical and pathological features. Moreover, LINE-1 hypomethylation was not significantly associated with overall survival, cancer specific survival, or disease-free survival (log-rank p = 0.30, p = 0.18 and p = 0.50, respectively). CONCLUSION: The LINE-1 methylation level appears not to be associated with poor prognosis in PC. The effect of the LINE-1 methylation level on the survival of PC patients needs to be confirmed in a larger-cohort study.
PURPOSE: Global DNA hypomethylation plays an important role in genomic instability and carcinogenesis. The long interspersed nucleotide element-1 (LINE-1) methylation level is a good surrogate marker of the global DNA methylation level. Previously, we demonstrated a strong relationship between LINE-1 hypomethylation and poor prognosis in certain cancers. However, the relationship between the LINE-1 methylation level and the clinical outcome of pancreatic cancer (PC) remains unclear. METHODS: We used a pyrosequencing assay to measure LINE-1 methylation levels in 126 samples of resected PC and evaluated the prognostic value of the LINE-1 methylation level. RESULTS: LINE-1 methylation levels were significantly lower in PC tissues than in matched noncancerous pancreatic tissues (p = 0.039, n = 36). The tumoral LINE-1 methylation range was 41.3-92.8 (n = 126, mean 77.7, median 78.5, standard deviation 5.7). The LINE-1 methylation level was unrelated to clinical and pathological features. Moreover, LINE-1 hypomethylation was not significantly associated with overall survival, cancer specific survival, or disease-free survival (log-rank p = 0.30, p = 0.18 and p = 0.50, respectively). CONCLUSION: The LINE-1 methylation level appears not to be associated with poor prognosis in PC. The effect of the LINE-1 methylation level on the survival of PC patients needs to be confirmed in a larger-cohort study.
Authors: Teresa M Holm; Laurie Jackson-Grusby; Tobias Brambrink; Yasuhiro Yamada; William M Rideout; Rudolf Jaenisch Journal: Cancer Cell Date: 2005-10 Impact factor: 31.743
Authors: Sojun Hoshimoto; Christine T Kuo; Kelly K Chong; Teh-Ling Takeshima; Yoshiki Takei; Michelle W Li; Sharon K Huang; Myung-Shin Sim; Donald L Morton; Dave S B Hoon Journal: J Invest Dermatol Date: 2012-03-08 Impact factor: 8.551
Authors: Nemanja Rodić; Jared P Steranka; Alvin Makohon-Moore; Allison Moyer; Peilin Shen; Reema Sharma; Zachary A Kohutek; Cheng Ran Huang; Daniel Ahn; Paolo Mita; Martin S Taylor; Norman J Barker; Ralph H Hruban; Christine A Iacobuzio-Donahue; Jef D Boeke; Kathleen H Burns Journal: Nat Med Date: 2015-08-10 Impact factor: 53.440
Authors: Rong Tang; Yiyin Zhang; Chen Liang; Jin Xu; Qingcai Meng; Jie Hua; Jiang Liu; Bo Zhang; Xianjun Yu; Si Shi Journal: PeerJ Date: 2020-09-28 Impact factor: 2.984
Authors: Brian Z Huang; Alexandra M Binder; Catherine A Sugar; Chun R Chao; Veronica Wendy Setiawan; Zuo-Feng Zhang Journal: Epigenomics Date: 2020-09-01 Impact factor: 4.778